XML 41 R20.htm IDEA: XBRL DOCUMENT
v3.23.1

EARNINGS PER SHARE | 3 Months Ended
--- | ---
Mar. 31, 2023
Earnings Per Share [Abstract] |
EARNINGS PER SHARE | EARNINGS PER SHARE Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
|  |  | Three Months Ended March 31,
|  |  |  |  | 2023 |  | 2022
Basic: |  |  |  |  |  |  |
Net income attributable to Edwards Lifesciences, Inc. |  |  |  |  | $ | 340.5 |  |  | $ | 373.6 |
Weighted-average shares outstanding |  |  |  |  | 607.5 |  |  | 622.1 |
Basic earnings per share |  |  |  |  | $ | 0.56 |  |  | $ | 0.60 |
Diluted: |  |  |  |  |  |  |
Net income attributable to Edwards Lifesciences, Inc. |  |  |  |  | $ | 340.5 |  |  | $ | 373.6 |
Weighted-average shares outstanding |  |  |  |  | 607.5 |  |  | 622.1 |
Dilutive effect of stock plans |  |  |  |  | 3.4 |  |  | 7.3 |
Dilutive weighted-average shares outstanding |  |  |  |  | 610.9 |  |  | 629.4 |
Diluted earnings per share |  |  |  |  | $ | 0.56 |  |  | $ | 0.59 |
Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 5.2 million and 1.7 million common shares for the three months ended March 31, 2023 and 2022, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration